Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Some of today’s most popular products promise better immune, adaptogenic, anti-inflammatory, gut, skin or joint health—or combinations of two or more of the above.
The company called the state’s regulation of pharmacy benefit managers “shortsighted,” as it would force the closure of Accredo, a specialty drug dispensary that supplies drugs it says aren’t available anywhere else in the state.
The agency had been suing the three largest pharmacy benefit managers over their alleged control of insulin prices. It reached agreements with CVS’ Caremark and Cigna’s Express Scripts earlier this year.
The collaboration between the chipmaker and Abridge, a developer of generative AI for healthcare, will involve data-sharing to improve Nvidia’s general-purpose models, which in turn will be used to make Abridge’s clinical offerings more efficient.
Cloud giant Amazon Web Services is expanding its 1½ -year-old HealthLake data-management service in two imaging-specific directions. In the process it’s drawing vocal buy-in from healthcare providers as well as imaging vendors.
An imaging industry supplier best known for a widely adopted radiology reporting platform is partnering on radiological artificial intelligence with a company that pioneered GPUs and accelerated computing.
An established radiopharmaceutical can now be applied with the FDA’s blessing when symptoms of cognitive decline point to the second most common form of degenerative dementia (after only Alzheimer’s disease).
With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.
RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.
More than 30% of surveyed PACS users are looking around for a potential replacement, according to an 82-page report from KLAS. “The U.S. PACS market is poised for change," the report's authors wrote.
Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.